Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBI
Chicago Bridge & Iron Nv
CBI
|
+$54.1M |
| 2 |
TW
TOWERS WATSON & CO COM STK CL A (DE)
TW
|
+$42.9M |
| 3 |
Teradata
TDC
|
+$40.2M |
| 4 |
Delta Air Lines
DAL
|
+$39.9M |
| 5 |
Monster Beverage
MNST
|
+$37.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$53.1M |
| 2 |
News Corp Class B
NWS
|
+$33.3M |
| 3 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$31.9M |
| 4 |
C.H. Robinson
CHRW
|
+$30.5M |
| 5 |
IM
Ingram Micro
IM
|
+$26.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 23.69% |
| 2 | Technology | 19.82% |
| 3 | Consumer Discretionary | 19.24% |
| 4 | Consumer Staples | 12.32% |
| 5 | Healthcare | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Barrett Business Services
BBSI
$810M
| $973K | 0.01% |
82,812
+5,640
| +7% | +$71.4K |
|
|
PGI
652
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
| $973K | 0.01% |
72,871
+4,552
| +7% | +$58K |
|
653
Northwest Natural Holdings
NWN
$2.11B
| $969K | 0.01% |
+20,556
| New | +$921K |
|
|
IPCM
654
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $968K | 0.01% |
21,895
+6,695
| +44% | +$292K |
|
|
DATA
655
DELISTED
Tableau Software, Inc.
DATA
| $964K | 0.01% |
+13,509
| New | +$847K |
|
|
TGNA
656
DELISTED
TEGNA Inc
TGNA
| $960K | 0.01% |
58,623
-101,483
| -63% | -$1.49M |
|
|
VVC
657
DELISTED
Vectren Corporation
VVC
| $958K | 0.01% |
+22,535
| New | +$901K |
|
|
PRFT
658
DELISTED
Perficient Inc
PRFT
| $943K | 0.01% |
48,452
-41,736
| -46% | -$756K |
|
|
INSY
659
DELISTED
Insys Therapeutics, Inc.
INSY
| $940K | 0.01% |
60,222
+26,258
| +77% | +$424K |
|
660
Ambarella
AMBA
$3.07B
| $930K | 0.01% |
29,822
-35,582
| -54% | -$941K |
|
661
ResMed
RMD
$33.5B
| $928K | 0.01% |
18,321
-511,695
| -97% | -$25.4M |
|
662
Halliburton
HAL
$28.9B
| $923K | 0.01% |
+13,005
| New | +$834K |
|
663
Steris
STE
$23.2B
| $922K | 0.01% |
17,236
+1,187
| +7% | +$61.1K |
|
664
Maximus
MMS
$3.05B
| $921K | 0.01% |
21,410
+11,150
| +109% | +$479K |
|
|
HZNP
665
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $914K | 0.01% |
+57,769
| New | +$825K |
|
666
HF Sinclair
DINO
$16.9B
| $907K | 0.01% |
20,771
-4,822
| -19% | -$237K |
|
|
REMY
667
DELISTED
REMY INTL INC NEW COMMON
REMY
| $902K | 0.01% |
38,649
-13,007
| -25% | -$315K |
|
|
ADT
668
DELISTED
ADT Corp
ADT
| $898K | 0.01% |
25,691
-18,653
| -42% | -$598K |
|
669
Amkor Technology
AMKR
$11.9B
| $889K | 0.01% |
+79,540
| New | +$734K |
|
|
URS
670
DELISTED
URS CORP
URS
| $879K | 0.01% |
19,172
-255,949
| -93% | -$11.8M |
|
671
Netflix
NFLX
$333B
| $877K | 0.01% |
+139,370
| New | +$754K |
|
672
Trinity Industries
TRN
$2.37B
| $873K | 0.01% |
+27,747
| New | +$786K |
|
673
DXP Enterprises
DXPE
$2.9B
| $872K | 0.01% |
11,548
-92,513
| -89% | -$8.01M |
|
674
Benchmark Electronics
BHE
$2.58B
| $871K | 0.01% |
34,187
-132,507
| -79% | -$3.12M |
|
675
Pacira BioSciences
PCRX
$991M
| $871K | 0.01% |
+9,486
| New | +$722K |
|
Similar funds
Joel Greenblatt's Q2 2014 Portfolio in Review
As of Q2 2014, Joel Greenblatt held 1,196 positions worth $7.99B, up 20% from $6.64B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.
Joel Greenblatt deployed $1.17B of net new capital in Q2 2014, opening 202 new positions and adding to 378 existing holdings. Its largest new stake was Chicago Bridge & Iron Nv: 679,782 shares worth $46.4M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was C.H. Robinson, an estimated $30.5M trimmed.
- Joel Greenblatt's largest Q2 2014 buy was Chicago Bridge & Iron Nv: 679,782 shares worth $46.4M.
- Joel Greenblatt added most to TOWERS WATSON & CO COM STK CL A (DE) in Q2 2014, an estimated $42.9M increase.
- Joel Greenblatt's biggest Q2 2014 reduction was C.H. Robinson, cutting an estimated $30.5M.
- Joel Greenblatt fully exited State Street SPDR S&P 500 ETF Trust in Q2 2014, selling an estimated $53.1M.
- Joel Greenblatt's ten largest holdings make up 6.9% of its $7.99B portfolio in Q2 2014.
- Joel Greenblatt opened 202 new positions and closed 216 in Q2 2014.
- Joel Greenblatt's portfolio value rose 20% quarter-over-quarter to $7.99B.
Based on Gotham Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.